Modern management of dandruff;Współczesne leczenie łupieżu

Polski Merkuriusz Lekarski

Volumn 20, Issue 115, 2006, Pages 121-124

  Nowicki, Roman ^a,b  

^a Katedra I Klinika Dermatologii   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Cyklopirox olamine; Dandruff; Imidazoles; Malassezia sp.; Seborrhoeic dermatitis; Selenium sulfide; Zinc pyrithione

Indexed keywords

ANTIFUNGAL AGENT; CICLOPIROXOLAMINE; COSMETIC; IMIDAZOLE DERIVATIVE; SALICYLIC ACID; SELENIUM; SELENIUM SULFIDE; SHAMPOO; SULFUR; TAR; UREA; ZINC;

CLINICAL FEATURE; DANDRUFF; DISEASE SEVERITY; HUMAN; HUMIDITY; MALASSEZIA FURFUR; PREVALENCE; PRURITUS; REVIEW; SEASONAL VARIATION; SKIN MANIFESTATION;

DERMATITIS, SEBORRHEIC; HUMANS;

EID: 31944449685     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Braun Falco O., Plewig G., Wolff H.H. i wsp.: Dermatology. Springer-Verlag, Berlin, Heidelberg 2000.
2. Bulmer A.C., Bulmer G.S.: The antifungal action of dandruff shampoos. Mycopathologia, 1999, 147, 63-65.
3. Faergemann J.: The role of the Malassezia yeasts in skin diseases. Mikol. Lek., 2004, 11, 129-132.
4. Faergemann J.: Pityrosporum species as a cause of allergy and infection. Allergy, 1999, 54, 413-419.
5. Gullon G.R., Muinelo A.P.: Comparative study to determine the efficacy, tolerance and cosmetic acceptance of shampoo containing 1.5% ciclopirox olamine versus a ketokonazole gel for the treatment of scalp seborrheic dermatitis. Dermatol. Cosmet., 2001, 11, 1001-1104.
6. Gupta A.K., Blum R.: Seborrheic dermatitis. J. Eur. Acad. Dermatol. Venerol., 2004, 18, 13-26.
7. Gupta A.K., Madzia S.E., Batra R.: Etiology and management of Seborrheic Dermatitis. Dermatology, 2004, 208, 89-93.
8. Gupta A.K., Nicol K.: The use of sulfur in dermatology. J. Drugs Dermatol., 2004, 4, 427-431.
9. Gupta A.K., Lebwohl M.: Ciclopirox 1% shampoo is a safe and effective treatment for seborrheic dermatitis. Int. J. Dermatol., 2004, 43(suppl. 1), 1-2.
10. Gupta A.K., Plott T.: Ciclopirox: a broad-spectrum antifungal with antibacterial and anti-inflammatory properties. Int. J. Dermatol., 2004, 43(suppl. 1), 3-8.
11. Han N.H., West D.P.: Scaly dermatoses. W: Allen L.V. i wsp.: eds. Handbook of Nonprescription Drugs, 12th ed. Washington DC, American Pharmaceutical Association, 2000, 633-646.
12. Harding C. R., Moore A. E., Rogers J. S. i wsp.: Dandruff: a condition characterized by decreased levels of intercellular lipids in scalp stratum corneum and impaired barrier function. Arch. Dermatol. Res., 2002, 294, 221-230.
13. Hay R.J., Graham-Brown R.A.C.: Dandruff and seborrhoeic dermatitis: causes and management. Clin. Exp. Dermatol., 1997, 22, 3-6.
14. Ive F.A.: An overview of experience with ketoconazole shampoo. BJCP., 1991, 45, 279-284.
15. Jabłońska S., Chorzelski T.: Choroby skóry. Wydawnictwo Lekarskie PZWL, Warszawa 2001.
16. Janniger C.K., Schwartz J.R.: Seborrheic dermatitis. Am. Fam. Physician. 1995, 52, 149-155.
17. Lavrijsen A.P.M., Bouwstra J.A., Gooris G.S. i wsp.: Reduced skin barrier function parallels abnormal stratum corneum lipid organisation in patients with lamellar ichthyosis. J. Invest. Dermatol., 1995, 105, 619-624.
18. Marks R., Pearse A.D., Walker A.P.: The effects of a shampoo containing zinc pyrithione on the control of dandruff. Br. J. Dermatol., 1985, 112, 415-422.
19. Miedziński F.: Choroby skóry i weneryczne. Wydawnictwo Lekarskie PZWL, Warszawa 1978, 411-413.
20. Monografia produktu. Stieprox® (szampon zawieraja̧cy 1.5% ciclopirox olamine). Stiefel Polska, Warszawa 2003.
21. Motta SM., Monti S., Sesana L. i wsp.: Ceramide composition of the psoriatic scale. Biochim. Biophys. Acta, 1993, 1182, 147-151.
22. Nenoff P., Haustein U.F.: In vitro susceptibility testing of Pityrosporum ovale against antifungal, antiseborrhoeic and antipsoriatic agents. Eur. Acad. Dermatol. Venereol., 1994, 3, 331-333.
23. Nowicki R.: Współczesne metody leczenia grzybic powierzchownych. W: Langner A. (red.): Współczesne leczenie wybranych chorób skóry. Warszawa, OIN "Polfa" sp. z o.o., 2002, 125-152.
24. Pierard-Franchimont C., Uhoda E., Loussouarn G. i wsp.: Effect of residence time on the efficacy of antidandruff shampoos. Int. J.Cosm. Sci., 2003, 25, 267-271.
25. Pierard-Franchimont C., Hermanns J.F., Degreef H. i wsp.: From axioms to new insights into dandruff. Dermatology, 2000, 200, 93-98.
26. Pray W.S.: Dandruff and seborrheic dermatitis. US Pharm., 2001, 28, 16-24.
27. Schmidt A.: Malassezia furfur: a fungus belonging to physiological skin flora and its relevance in skin disorders. Cutis, 1997, 59, 21-24.
28. Schuster S.: The aetiology of dandruff and the mode of action of therapeutic agents. Br. J. Dermatol., 1984, 111, 235-242.
29. Selsun blue. Informacja o leku dla pacjenta. Abbot France SA, 2004.
30. Tooley P.: Dandruff: An irritating problem. Practitioner, 1990, 234, 593-596.
31. Van Cutsem J., Van Gerven F., Fransen J. i wsp.: The in vitro antifungal activity of ketoconazole, zinc pyrithione, and selenium sulphide, against Pityrosporum and their efficacy as a shampoo in the treatment of experimental pityrosporosis in guinea pigs. J. Am. Acad. Dermatol., 1990, 22, 993-998.
32. Vardy D.A., Zvulunov A., Tchetov T. i wsp.: A double-blind, placebo-controlled trial of ciclopiroxolamine 1% shampoo for treatment of scalp seborrheic dermatitis. J. Dermatol. Treatment, 2000, 11, 73-77.
33. Warner R., Schwartz J.R., Boissy Y. i wsp.: Dandruff has an altered stratum corneum ultrastructure that is improved with zinc pyrithione shampoo. J. Am. Acad. Dermatol., 2001, 45, 897-903.
34. Watanabe S., Kano R., Sato H.: The effects of Malassezia yeasts on cytokine production by human keratinocytes. Invest Dermatol., 2001, 116, 769-773.
35. West D.P., Kano R., Sato H. i wsp.: Dermatologic Products. W: Covington T.R. i wsp.: eds. Handbook of Nonprescription Drugs, 11th ed. Washington DC, American Pharmaceutical Association, 1996, 537-568.
36. Xiong L., Dai Y.-L.: Correlation of the density of the yeast Malassezia with the clinical severity of dandruff and health of the scalp. Chin. J. Clin. Rehab., 2004, 8, 2080-2081.
37. Yamamoto A., Serizawa S., Ito M. i wsp.: Stratum corneum lipid abnormalities in atopic dermatitis. Arch. Dermatol. Res., 1991, 283, 219-223.